Related Experiment Video
Updated: Jun 3, 2026

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
Metachronous melanoma in breast reconstruction patients
Sarita V Vamadeva1, Simon P Mackey, Martin E Jones
1Melanoma and Skin Cancer Unit (MASCU), Queen Victoria Hospital, East Grinstead RH19 3DZ, United Kingdom. sarita@london.com
Summary
Malignant melanoma incidence is rising. This study details managing impalpable axillary melanoma deposits in a patient who underwent breast reconstruction using a latissimus dorsi (LD) flap, a unique clinical scenario.
Area of Science:
- Oncology
- Surgical Oncology
- Plastic Surgery
Background:
- Malignant melanoma incidence and mortality have significantly increased in England and Wales over the last 30 years.
- A substantial majority of primary melanoma patients (90%) present without clinically detectable lymph node involvement.
- Managing occult lymph node metastases in melanoma is crucial for accurate staging and treatment planning.
Observation:
- This paper presents a unique case of a patient with impalpable axillary melanoma deposits.
- The patient had undergone a pedicled latissimus dorsi (LD) flap reconstruction for the ipsilateral breast.
- The management of these impalpable deposits in the context of LD flap reconstruction is the focus.
Findings:
- The study describes the specific management strategy employed for impalpable axillary melanoma deposits in this complex reconstructive setting.
- This approach addresses the challenge of staging and treating melanoma in patients with prior breast reconstruction.
- The successful management of this rare presentation is detailed.
Implications:
- This case highlights a novel approach to managing melanoma metastases in patients with specific surgical histories.
- It contributes to the literature by describing a previously undocumented clinical scenario and its management.
- The findings may inform surgical decision-making and oncological care for similar complex melanoma cases.